Carlos Mena-Hurtado
Overview
Explore the profile of Carlos Mena-Hurtado including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
136
Citations
864
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Attaran R, Babapour G, Mena-Hurtado C, Ochoa Chaar C
Interv Cardiol Clin
. 2025 Mar;
14(2):283-296.
PMID: 40049854
Chronic venous insufficiency is common and is associated with progressive leg discomfort, heaviness, edema, discoloration and ulceration, and venous obstruction, reflux, or both. Venous insufficiency and varicose veins are widespread...
2.
Lal B, Roubin G, Meschia J, Jones M, Heck D, Sternbergh 3rd W, et al.
J Vasc Surg
. 2025 Mar;
PMID: 40024381
Background: Intra-procedural atheroembolization during carotid artery stenting (CAS) can be reduced through careful patient selection, consideration of vascular anatomy and lesion characteristics, operator and institutional experience, peri-procedural antithrombotic and antiplatelet...
3.
Edjimbi J, Shah N, Kwaah P, Grimshaw A, Regan C, Nagpal S, et al.
J Vasc Surg
. 2025 Feb;
PMID: 40015609
Introduction: Peripheral arterial disease (PAD) is highly prevalent and has a well-established association with diabetes mellitus (DM). However, it remains unclear whether DM worsens clinical outcomes after lower extremity revascularization...
4.
Callegari S, Romain G, Capuano I, Cleman J, Scierka L, Smolderen K, et al.
Vasc Med
. 2025 Feb;
:1358863X251320347.
PMID: 39992181
Introduction: Reintervention following peripheral vascular intervention (PVI) for peripheral artery disease (PAD) is common. Guideline-directed medical therapy (GDMT) is recommended post-PVI, yet its association with reintervention outcomes remains unclear. Methods:...
5.
Smolderen K, Ujueta F, Buckley Behan D, Vlaeyen J, Jackson E, Peters M, et al.
Circ Cardiovasc Qual Outcomes
. 2025 Feb;
:e000135.
PMID: 39925269
Peripheral artery disease (PAD) is an atherosclerotic condition that affects a growing number of individuals worldwide, with estimates exceeding 220 million. One of the central hallmarks of PAD is lower...
6.
Mosarla R, Chowdhury M, Smolderen K, Mena-Hurtado C, Spertus J, Yeh R, et al.
Am J Cardiol
. 2025 Feb;
243:22-31.
PMID: 39894333
Improving health status is a primary indication for peripheral endovascular intervention (PVI) for symptomatic peripheral arterial disease. The data informing mid- and long-term changes and predictors of health status following...
7.
Malas M, Hamouda M, Farber A, Menard M, Conte M, Rosenfield K, et al.
J Vasc Surg
. 2025 Jan;
PMID: 39846933
Background: Chronic limb-threatening ischemia (CLTI) in patients with chronic kidney disease (CKD) has a high risk of poor outcomes. We aimed to compare the outcomes of lower extremity revascularization in...
8.
Kluger J, Romain G, Mena-Hurtado C, Grubman S, Pajarillo C, Cleman J, et al.
Catheter Cardiovasc Interv
. 2025 Jan;
105(4):927-937.
PMID: 39789704
Background: Evaluating health status changes following transfemoral carotid artery stenting (TF-CAS) is essential for assessing procedural success, but meaningful clinical changes are unknown. We aimed to determine minimal clinically important...
9.
Odu T, Romain G, Scierka L, Cleman J, Callegari S, Jacque F, et al.
Vasc Med
. 2025 Jan;
:1358863X241306406.
PMID: 39760470
No abstract available.
10.
Callegari S, Romain G, Pajarillo C, Cleman J, Scierka L, Smolderen K, et al.
J Soc Cardiovasc Angiogr Interv
. 2024 Nov;
3(9):102170.
PMID: 39575211
No abstract available.